Prof. Ola Mohamed Reda Mahmoud Hafez Khorshid is a medical oncology professor associated with the National Cancer Institute at Cairo University, Egypt. The Egyptian Health Council lists her as Head of the Department of Oncology at the institute, and the National Cancer Institute's 2025 congress programme also identifies her as chair of its Medical Oncology and Hematology Department.

Specialized committees for guidelines

+1

Medical oncology focuses on the diagnosis and treatment of cancer using medicines and coordinated multidisciplinary care. Depending on the disease, treatment may involve chemotherapy, immunotherapy, targeted medicines, hormone therapy and other systemic approaches. Treatment decisions depend on cancer type, stage, pathology, molecular characteristics, previous treatments and the patient's general health.

Cancer assessment and treatment planning

A medical oncology consultation usually begins with a detailed review of the patient's diagnosis, symptoms, medical history and previous investigations. Pathology reports, biopsy findings, imaging, laboratory tests and relevant molecular studies may help establish the diagnosis and determine the stage of disease.

Once the available evidence has been reviewed, the oncology team can discuss treatment options and the purpose of each intervention. Some treatments aim to eliminate cancer, while others aim to control its growth, relieve symptoms or improve quality of life. The goals depend on the individual case.

Systemic cancer treatment

Chemotherapy uses medicines that damage or inhibit the growth of cancer cells. It may be recommended before surgery, after surgery or as a primary treatment, depending on the cancer. Side effects vary with the medicines used and can require supportive medication, blood monitoring and adjustments to the treatment schedule.

Targeted therapies are designed to act on particular biological features of cancer cells. Their suitability often depends on molecular or genetic testing. Immunotherapy uses the immune system to help recognize and attack cancer cells and may be appropriate for selected cancers, but it is not effective or suitable in every situation.

A medical oncologist helps evaluate the potential benefits and risks of these options and coordinates monitoring during treatment.

Multidisciplinary cancer care

Cancer management often involves more than one specialty. Depending on the diagnosis, a patient may need input from surgical oncology, radiation oncology, pathology, diagnostic radiology, genetics, nursing, nutrition and palliative care. A multidisciplinary team helps coordinate decisions and reduces the risk of treatment being planned in isolation.

The National Cancer Institute at Cairo University is an academic cancer institution, making its medical oncology department relevant to patients researching specialist cancer assessment and treatment in Egypt. Prof. Khorshid's documented departmental leadership supports her inclusion in an oncology directory, though individual treatment services and appointment availability should be checked directly.

Specialized committees for guidelines

+1

Clinical research and evidence-based care

Academic oncology includes evaluating research findings, updating clinical protocols and contributing to the development of cancer-treatment guidelines. The Egyptian Health Council's oncology-guideline programme lists Prof. Khorshid among its recognized oncology professionals.

Egyptian Health Council

+1

For patients, evidence-based treatment means that recommendations are considered in light of current medical knowledge, established clinical guidance and the patient's circumstances. Participation in a clinical trial, where available, requires a separate eligibility assessment and informed consent.

Information for international patients

Patients travelling to Egypt for oncology consultations should bring their biopsy and pathology reports, imaging files, treatment summaries, previous medication records, allergy information and recent laboratory results. If molecular or genetic testing has already been performed, those results may also be relevant.

Before travelling, patients should confirm whether the doctor accepts new patients, whether the appointment is in person or remote, which hospital department will coordinate care and whether any additional diagnostic tests are required. Cancer treatment schedules and expected costs should be discussed with the treating institution.

Prof. Ola Khorshid's documented leadership at Cairo University's National Cancer Institute makes her a relevant featured specialist for a directory of oncology services in Egypt. Her clinical availability, detailed subspecialty interests and years of experience should be confirmed with the institute before the profile is published as a complete physician biography.